Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial. (Record no. 17550365)

MARC details
000 -LEADER
fixed length control field 01596 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515094848.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200902s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1463-1326
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/j.1463-1326.2007.00794.x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hovens, M M C
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20090220
245 00 - TITLE STATEMENT
Title Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Diabetes, obesity & metabolism
Date of publication, distribution, etc. Aug 2008
300 ## - PHYSICAL DESCRIPTION
Extent 668-74 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aspirin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Atherosclerosis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element C-Reactive Protein
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cross-Over Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes Mellitus, Type 2
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetic Angiopathies
General subdivision prevention & control
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interleukin-6
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Platelet Aggregation Inhibitors
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Snoep, J D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Groeneveld, Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Frölich, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tamsma, J T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huisman, M V
773 0# - HOST ITEM ENTRY
Title Diabetes, obesity & metabolism
Related parts vol. 10
-- no. 8
-- p. 668-74
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/j.1463-1326.2007.00794.x">https://doi.org/10.1111/j.1463-1326.2007.00794.x</a>
Public note Available from publisher's website

No items available.